Alan Hambelton

Alan heads Cooley’s Seattle corporate practice. He brings nearly 20 years of experience advising high-growth companies throughout their life cycles, from formation to exit, across a range of industries, including life sciences, software, ecommerce, real estate, fintech, space technology and clean technology. Alan guides these companies on matters spanning corporate securities, private financings, M&A, public offerings, corporate governance and general counseling.

Alan is a trusted advisor to startups, management, boards of directors and investors, bringing a calm perspective and a focus on efficiency and the issues that truly matter. His experience with companies through all stages of growth enables him to look ahead and help set up his companies for success.

In addition to his work with private companies, Alan has represented issuers and leading investment banks in capital markets transactions, raising billions of dollars. Oftentimes, these are organizations he first represented as private companies – in some cases from formation – through their initial public offerings and beyond.

Alan’s representative clients in capital markets transactions include Accolade, ACV Auctions, Dutch Bros, Etsy, Instructure, Shake Shack, Tilray, Zulily, Alder Biopharmaceuticals, Aquinox Pharmaceuticals, Cytokinetics, Eliem Therapeutics and Seagen. His underwriter-side clients include Avalara, Apptio, Leona Bio, Neoleukin and Redfin.

Alan is a frequent speaker on various topics at institutions and organizations including the University of Washington, Creative Destruction Lab, Life Science Washington and the Fred Hutchinson Cancer Center.

Outside his practice, Alan enjoys spending time with his family, playing music and coaching youth sports.